Masako Kikuchi

1.5k total citations
52 papers, 1.0k citations indexed

About

Masako Kikuchi is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Masako Kikuchi has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Hematology and 12 papers in Immunology. Recurrent topics in Masako Kikuchi's work include Autoimmune and Inflammatory Disorders Research (16 papers), Inflammasome and immune disorders (9 papers) and Cellular Mechanics and Interactions (4 papers). Masako Kikuchi is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (16 papers), Inflammasome and immune disorders (9 papers) and Cellular Mechanics and Interactions (4 papers). Masako Kikuchi collaborates with scholars based in Japan, Iran and China. Masako Kikuchi's co-authors include Yasushi Kawakami, Shumpei Yokota, Akiko Kubodera, Takaharu Nomura, Takako Miyamae, Tomoyuki Imagawa, Kosçak Maruyama, Masaaki Mori, Ryoki Hara and Hajime Sawada and has published in prestigious journals such as PLoS ONE, Cancer and Scientific Reports.

In The Last Decade

Masako Kikuchi

52 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Kikuchi Japan 18 310 173 171 156 123 52 1.0k
Jeffrey C. Philcox Australia 23 383 1.2× 79 0.5× 357 2.1× 77 0.5× 27 0.2× 46 2.4k
Ross M. Graham Australia 22 485 1.6× 106 0.6× 425 2.5× 80 0.5× 125 1.0× 42 1.6k
Silvia Montoro‐García Spain 23 684 2.2× 270 1.6× 115 0.7× 95 0.6× 301 2.4× 52 1.4k
Tamás Fazekas Hungary 15 164 0.5× 61 0.4× 94 0.5× 202 1.3× 174 1.4× 111 1.1k
Mizuho Nosaka Japan 24 378 1.2× 279 1.6× 141 0.8× 106 0.7× 137 1.1× 71 1.3k
Nathan Kaufman United States 21 177 0.6× 189 1.1× 542 3.2× 209 1.3× 89 0.7× 104 1.6k
Qun Jiang United States 21 542 1.7× 213 1.2× 43 0.3× 129 0.8× 135 1.1× 70 1.3k
Stanley A. Mendoza United States 25 796 2.6× 79 0.5× 78 0.5× 244 1.6× 75 0.6× 88 2.1k
İsmail Kurt Türkiye 20 301 1.0× 86 0.5× 110 0.6× 89 0.6× 59 0.5× 55 982

Countries citing papers authored by Masako Kikuchi

Since Specialization
Citations

This map shows the geographic impact of Masako Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Kikuchi more than expected).

Fields of papers citing papers by Masako Kikuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Kikuchi. The network helps show where Masako Kikuchi may publish in the future.

Co-authorship network of co-authors of Masako Kikuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Kikuchi. A scholar is included among the top collaborators of Masako Kikuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Kikuchi. Masako Kikuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Masaaki, Takuma Hara, Masako Kikuchi, et al.. (2018). Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial. Scientific Reports. 8(1). 1994–1994. 50 indexed citations
2.
Yanagimachi, Masakatsu, Takuya Naruto, Takako Miyamae, et al.. (2017). PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis. PLoS ONE. 12(2). e0171961–e0171961. 10 indexed citations
3.
Hara, Ryoki, Kenichi Nishimura, Tomo Nozawa, et al.. (2015). A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.. PubMed. 25(6). 858–64. 5 indexed citations
4.
Shiota, Mitsutaka, Xi Yang, Tatsuya Morishima, et al.. (2015). Somatic Mosaicism for a NRAS Mutation Associates with Disparate Clinical Features in RAS-associated Leukoproliferative Disease: a Report of Two Cases. Journal of Clinical Immunology. 35(5). 454–458. 29 indexed citations
5.
Nozawa, Tomo, Masako Kikuchi, Kiyotaka Nagahama, et al.. (2014). Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis. Modern Rheumatology. 25(2). 210–214. 8 indexed citations
6.
7.
Miyamae, Takako, Takehito Yoshida, Masako Kikuchi, et al.. (2013). Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Report. 18(1). 12–19. 62 indexed citations
8.
Mori, Masaaki, Masakatsu Yanagimachi, Takako Miyamae, et al.. (2013). Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population. PLoS ONE. 8(8). e72551–e72551. 23 indexed citations
9.
Mori, Masaaki, Tomoyuki Imagawa, Ryoki Hara, et al.. (2012). Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series. The Journal of Rheumatology. 39(4). 864–867. 54 indexed citations
10.
Yanagimachi, Masakatsu, Takako Miyamae, Takuya Naruto, et al.. (2010). Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis. Journal of Human Genetics. 56(3). 196–199. 18 indexed citations
11.
Miyamae, Takako, Yutaka Inaba, Gen Nishimura, et al.. (2010). Effect of anakinra on arthropathy in CINCA/NOMID syndrome. Pediatric Rheumatology. 8(1). 9–9. 25 indexed citations
12.
Yanagimachi, Masakatsu, Takuya Naruto, Takuma Hara, et al.. (2010). Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. British Journal of Clinical Pharmacology. 71(2). 237–243. 41 indexed citations
13.
Ichikawa, Kazushi, Masako Kikuchi, Saoko Takeshita, & Atsuo Nezu. (2008). A case of chronic recurrent cerebellar ataxia responding to steroid therapy. Brain and Development. 31(1). 83–85. 8 indexed citations
14.
Sugiyama, Akiko, et al.. (1999). Protective Effect of Aged Garlic Extract on the Small Intestinal Damage of Rats Induced by Methotrexate Administration. Planta Medica. 65(6). 545–548. 22 indexed citations
15.
Nomura, Takaharu, Masako Kikuchi, Akiko Kubodera, & Yasushi Kawakami. (1997). Proton‐donative antioxidant activity of fucoxanthin with 1,1‐Diphenyl‐2‐Picrylhydrazyl (DPPH). IUBMB Life. 42(2). 361–370. 157 indexed citations
16.
Kikuchi, Masako, et al.. (1996). Natural killing activity in patients with spontaneous regression of malignant lymphoma. Journal of Clinical Immunology. 16(6). 334–339. 19 indexed citations
17.
Kikuchi, Masako, et al.. (1995). Fucoxanthin, an antioxidative substance from marine diatom Phaeodactylum tricornutum. 3(1). 132–135. 5 indexed citations
18.
Shibata, Keisuke, Yoshinori Shimamoto, Kenji Suga, et al.. (1995). Adult T‐cell leukemia/lymphoma with two distinct clones in the peripheral blood and lymph node. American Journal of Hematology. 48(2). 116–119. 9 indexed citations
19.
Shimamoto, Yoshinori, et al.. (1993). Spontaneous regression in adult T-cell leukemia/lymphoma. Cancer. 72(3). 735–740. 34 indexed citations
20.
Ueda, Hiroshi, et al.. (1992). Antigen Responsive Antibody–Receptor Kinase Chimera. Bio/Technology. 10(4). 430–433. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey C. Philcox Breakdown of academic impact, for papers by Ross M. Graham Breakdown of academic impact, for papers by Silvia Montoro‐García Breakdown of academic impact, for papers by Tamás Fazekas Breakdown of academic impact, for papers by Mizuho Nosaka Breakdown of academic impact, for papers by Nathan Kaufman Breakdown of academic impact, for papers by Qun Jiang Breakdown of academic impact, for papers by Stanley A. Mendoza Breakdown of academic impact, for papers by İsmail Kurt
Rankless by CCL
2026